Humanity, Quest Diagnostics Offer Biological Age Test via Questhealth.com
Humanity Health and Quest Diagnostics (DGX) launched a biological age test in the US via Quest’s platform. The $29 add-on uses biomarkers from routine blood tests to estimate biological age and track changes over time. Developed with Imperial College London, the model was validated on over 306,000 participants. The service is available at Quest’s 2,000 service centers.
How this was made
The 30-second read
Why it matters
The partnership expands Quest's consumer health portfolio, aiming to capture preventive health market share.
Market read
Introduces a novel consumer health product that could modestly boost Quest Diagnostics' revenue and market perception.
What to watch
Potential regulatory scrutiny of wellness claims and competition from other at-home testing firms.
Background
Quest Diagnostics (DGX) partners with Humanity Health to offer a new biological age test via its QuestHealth.com platform.
Ticker impact
Quest Diagnostics announced the launch of Humanity Biological Age test on its consumer platform, a new product offering.
Small upside pressure if market views the service as a growth catalyst.
The service targets preventive health consumers; impact depends on adoption rates.
Market effects
May signal growing consumer health testing demand within diagnostics sector.
U.S. market focus; limited immediate regional effect.
Limited, as service currently U.S.-only.
Counterpoint
Adoption could be slower than expected, limiting revenue impact.
Key entities
- CompanyQuest Diagnostics
Public diagnostics company (ticker DGX) launching new service.
- CompanyHumanity Health
Private health tech firm providing the biological age model.
